Shi-Ming Tu MD
Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Join to View Full Profile
UAMS Medical Center449 Jack Stephens Drive Winthrop P. Rockefeller Cancer Institute, Seventh FloorLittle Rock, AR 72205
Phone+1 501-686-8530
Dr. Tu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1990 - 1993
University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 1989 - 1990- University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1987 - 1990
- University of Illinois College of Medicine at ChicagoInternship, Internal Medicine, 1987 - 1988
Washington University in St. Louis School of MedicineClass of 1987
Certifications & Licensure
CA State Medical License 1992 - Present
FL State Medical License 2021 - Present
AR State Medical License 2021 - 2025
TX State Medical License 1993 - 2024
OK State Medical License 2020 - 2021
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer Start of enrollment: 2002 Apr 01
- Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases Start of enrollment: 2002 Feb 01
- Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases Start of enrollment: 2004 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Doxorubicin, Paclitaxel, and Cisplatin (ATP) for Relapsed/Refractory Germ Cell Tumors.Jenny J Xiang, Matthew T Campbell, Shi-Ming Tu, John Araujo, Yago Nieto
Clinical Genitourinary Cancer. 2024-12-01 - Epithelioid trophoblastic tumor in male patients with germ cell tumor: A clinicopathologic analysis of five cases.Georges C Tabet, Lan Zheng, Hossein Hosseini, John Ward, Louis Pisters
Human Pathology. 2024-11-01 - 1 citationsGerm Cell Tumor of the Testis: Lethal Subtypes of a Curable Cancer.Jamaal C Jackson, Darren Sanchez, Andrew C Johns, Matthew T Campbell, Ahmet M Aydin
Journal of Clinical Medicine. 2024-06-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
